These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28536720)

  • 21. N-terminal acetylation of annexin A2 is required for S100A10 binding.
    Nazmi AR; Ozorowski G; Pejic M; Whitelegge JP; Gerke V; Luecke H
    Biol Chem; 2012 Oct; 393(10):1141-50. PubMed ID: 23091277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo.
    Stark K; Schubert I; Joshi U; Kilani B; Hoseinpour P; Thakur M; Grünauer P; Pfeiler S; Schmidergall T; Stockhausen S; Bäumer M; Chandraratne S; von Brühl ML; Lorenz M; Coletti R; Reese S; Laitinen I; Wörmann SM; Algül H; Bruns CJ; Ware J; Mackman N; Engelmann B; Massberg S
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):772-786. PubMed ID: 29419408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
    Singh S; Houng AK; Reed GL
    Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans.
    Fang W; Fa ZZ; Xie Q; Wang GZ; Yi J; Zhang C; Meng GX; Gu JL; Liao WQ
    CNS Neurosci Ther; 2017 Apr; 23(4):291-300. PubMed ID: 28130864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-Derived TGF-β1 Promotes Deep Vein Thrombosis.
    Zhang S; Li Y; Zhang J; Sun Y; Chu X; Gui X; Tong H; Ding Y; Ju W; Xu M; Li Z; Zeng L; Xu K; Qiao J
    Thromb Haemost; 2024 Jul; 124(7):641-648. PubMed ID: 38151026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats.
    Zhou J; May L; Liao P; Gross PL; Weitz JI
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):863-9. PubMed ID: 19265029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
    Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
    Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated MiR-9-5p Protects Against Inflammatory Response in Rats with Deep Vein Thrombosis via Inhibition of NF-κB p50.
    Ou M; Zhang Y; Cui S; Zhao S; Tu J
    Inflammation; 2019 Dec; 42(6):1925-1938. PubMed ID: 31463646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Danhong Huayu Koufuye prevents venous thrombosis through antiinflammation via Sirtuin 1/NF-κB signaling pathway.
    Liu H; Li P; Lin J; Chen W; Guo H; Lin J; Liu J; Lu Z; Yao X; Chen Y; Lin B
    J Ethnopharmacol; 2019 Sep; 241():111975. PubMed ID: 31141719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased venous thrombosis with an oral inhibitor of P selectin.
    Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
    J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombotic effects of heme-degrading and heme-binding proteins.
    Nath KA; Grande JP; Belcher JD; Garovic VD; Croatt AJ; Hillestad ML; Barry MA; Nath MC; Regan RF; Vercellotti GM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H671-H681. PubMed ID: 32004074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice.
    Bochenek ML; Bauer T; Gogiraju R; Nadir Y; Mann A; Schönfelder T; Hünig L; Brenner B; Münzel T; Wenzel P; Konstantinides S; Schäfer K
    Blood Adv; 2018 Jun; 2(11):1300-1314. PubMed ID: 29891592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.
    Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N
    Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells.
    Inokuchi J; Narula N; Yee DS; Skarecky DW; Lau A; Ornstein DK; Tyson DR
    Int J Cancer; 2009 Jan; 124(1):68-74. PubMed ID: 18924133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis.
    Malaponte G; Signorelli SS; Bevelacqua V; Polesel J; Taborelli M; Guarneri C; Fenga C; Umezawa K; Libra M
    PLoS One; 2015; 10(7):e0132496. PubMed ID: 26192925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.
    Deatrick KB; Luke CE; Elfline MA; Sood V; Baldwin J; Upchurch GR; Jaffer FA; Wakefield TW; Henke PK
    J Vasc Surg; 2013 Nov; 58(5):1375-1384.e2. PubMed ID: 23490298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model.
    Wang C; Yang F; Xu Z; Shi D; Chen D; Dai J; Gu N; Jiang Q
    Thromb Res; 2013 Jan; 131(1):e31-8. PubMed ID: 23199547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
    He KL; Deora AB; Xiong H; Ling Q; Weksler BB; Niesvizky R; Hajjar KA
    J Biol Chem; 2008 Jul; 283(28):19192-200. PubMed ID: 18434302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative binding of annexin A2 to cholesterol- and phosphatidylinositol-4,5-bisphosphate-containing bilayers.
    Drücker P; Pejic M; Grill D; Galla HJ; Gerke V
    Biophys J; 2014 Nov; 107(9):2070-81. PubMed ID: 25418092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective tissue factor/factor VIIa Inhibitor, ER-410660, and its prodrug, E5539, have anti-venous and anti-arterial thrombotic effects with a low risk of bleeding.
    Nagakura T; Tabata K; Kira K; Hirota S; Clark R; Matsuura F; Hiyoshi H
    Thromb Res; 2013 Aug; 132(2):271-9. PubMed ID: 23827699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.